Half cell solar panels, which divide conventional full-sized cells into two electrically independent halves, have moved from ...

No country has affected global solar panel supply chains more than the United States. Since the boom of solar in the early ...

Reducing manual touchpoints is an important part of supporting more consistent and scalable manufacturing processes.

Cell and gene therapy (CGT) has evolved from a niche research pursuit into a central force in biopharmaceutical innovation. By engineering living cells and genetic material to repair or replace faulty ...

Modern manufacturing is moving away from pure automation and toward something far more interesting: a factory floor where artificial intelligence works alongside people. Instead of just speeding up ...

Sony and Cellares announced a joint development collaboration Sept. 12. The two companies say the partnership aims to integrate Sony’s cell-sorting and analytical technologies into the Cell Shuttle, ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced that it has expanded its collaboration with ...

Walk into a modern manufacturing facility today, and you’ll see something that looks nothing like the factories of decades past. You’ll see data dashboards, AI-driven monitoring systems, and highly ...

Henniker Plasma, a leading manufacturer of plasma treatment systems, announces the launch of its Stratus Plasma Manufacturing Cell range — a fully integrated, turnkey solution that combines advanced ...

Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...